Tirzepatide 5 mg dosage: what this stage of treatment actually means

Four weeks in, and your prescriber has just changed the number on your pen

Picture this: your first Mounjaro pen is finished, you've had your follow-up clinical review, and the prescription that arrives says 5 mg. For some people that feels significant. For others it raises a quiet worry — will the side effects start again? The honest answer is that moving to 5 mg is entirely expected. The 2.5 mg starting dose isn't intended to produce dramatic results; it exists to let your body adjust to tirzepatide before the dose does more meaningful work. Think of it as your system getting its bearings.

At 5 mg, the dual GIP and GLP-1 receptor activity that makes tirzepatide distinct from older weight-loss injections begins to show more clearly. Appetite suppression typically becomes more noticeable, and for many patients this is the point at which food noise (the persistent background pull toward eating) starts to quieten. The NHS medicines page for tirzepatide describes this gradual titration as a deliberate part of the treatment design, not a sign that the earlier dose wasn't working.

If you're thinking about how 5 mg fits into the broader picture, the full tirzepatide dosing overview covers the whole schedule from start to maintenance.

Side effects at 5 mg: what's different from 2.5 mg, and what usually passes

GI side effects (nausea, loose stools, slowed digestion, a heavier feeling after small meals) are most common when tirzepatide is first started and when the dose goes up. Moving to 5 mg counts as a dose increase, so it's reasonable to expect a brief recurrence. Most people find any flare settles within seven to fourteen days as the body recalibrates.

Practical things that tend to help: eating smaller portions more slowly, avoiding fatty or heavily spiced meals in the first week or two after the increase, and staying well hydrated. Constipation is common alongside the more talked-about GI effects, so fibre and fluid matter. If symptoms are severe, persistent, or include sharp abdominal pain that radiates to your back, contact a clinician promptly, the MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines, and that symptom pattern warrants same-day assessment.

You can report any suspected side effects through the MHRA Yellow Card scheme, which helps regulators monitor real-world safety data across the whole patient population.

Is 5 mg a maintenance dose, or is there further to go?

For the majority of patients, 5 mg is a transitional dose rather than a long-term stopping point. The licensed schedule continues through 7.5 mg, 10 mg, 12.5 mg, and up to 15 mg, with typical four-week intervals between increases. Whether and when you move beyond 5 mg depends on how well you're tolerating the current dose, the weight response your prescriber is seeing, and your own clinical circumstances.

Some patients do stay at 5 mg for longer than four weeks, if side effects are significant, the prescriber may recommend holding the dose until things settle before going further. That's not a failure; it's exactly how the schedule is designed to be used. Clinical evidence from the SURMOUNT-1 trial, published in the New England Journal of Medicine, showed that greater average weight reductions came with higher doses over 72 weeks (around 20 to 21 percent at 15 mg) which is why titration toward the highest tolerated dose matters over time.

If you're curious about what comes next, the 10 mg dosage page covers what that stage typically involves, and if you'd like a closer look at what the 10 mg tirzepatide dosage means in practice, that detail is worth reading before your next review. There's also more on the ceiling dose at tirzepatide's maximum dose.

What your prescriber looks at before moving you up from 5 mg

At nume, every repeat order is clinically reviewed before it's dispensed, there are no automatic refills. When you're due to step from 5 mg toward 7.5 mg, the prescriber looks at your current weight, any side-effect history you've reported, and whether 5 mg has been tolerated well enough to support a safe increase. If you order before midday on a working day, the clinical review happens the same day; your next pen can be with you the following morning via DPD tracked delivery, which fits neatly around most people's routines.

For patients transferring from another provider or requesting a dose increase mid-treatment, evidence of your current dose is needed before the prescription is issued, that's not bureaucracy, it's how a responsible prescriber protects you. Details of what's involved are on the Mounjaro treatment page, and if cost is a factor in how you're thinking about ongoing treatment, the Mounjaro price comparison page sets out the market context honestly. When you're ready to talk through where you are in your dosing journey, our prescribers are available seven days a week, speak to our prescribers through a free consultation.